Patrick Burnett, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 138,352 shares at $10.29 ($1.4M) on 2024-11-14, disclosed to the SEC on 2024-11-18.
Open-market sale of $1.4M ARQT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.29 | 18,377 | $189K | 13.3% |
| 2 | $10.29 | 18,377 | $189K | 13.3% |
| 3 | $10.29 | 50,749 | $522K | 36.7% |
| 4 | $10.29 | 50,749 | $522K | 36.7% |
| 5 | $10.03 | 100 | $1K | 0.1% |
| Total | $10.29 avg | 138,352 |
| $1.4M |
| 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $25K | — | Filing → |
| ARQT | SELL | 2026-05-13 | $5K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $16K | — | Filing → |